Eosinophilic oesophagitis (EoE) is still inadequately treated in terms of its association with other type 2 inflammatory diseases (T2). Italian researchers attempted to close this gap. Their conclusion: In EoE patients, it is no longer sufficient to rely on medical history or isolated specialist input. A structured, multidisciplinary assessment improves diagnostic accuracy, identifies therapeutic targets and enables a more individualized treatment plan.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- Disorders of the Gut-Brain Interaction
Rome V Criteria: What Has Changed, and What Has Remained the Same?
- Tourette Syndrome
What can be done to treat this tic disorder?
- Chronic Hepatitis B: Is a Cure in Sight?
Phase III Trial of Temporary Treatment with Bepirovirsen Was Successful
- Congenital Vascular Malformations
Personalized Treatment Before a Planned Pregnancy
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Clinically Suspected Arthralgias
“Watchful waiting” or intervention?
- Tumors of the Calcaneus
Diagnostic Challenges of Rare Heel Tumors
- Upper GI Tract Bleeding: Hematemesis, Hematochezia, or Melena?